We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF
SBIO

48 hedge funds and large institutions have $44.6M invested in ALPS Medical Breakthroughs ETF in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 20 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more call options, than puts

Call options by funds: $258K | Put options by funds: $73K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

51% more capital invested

Capital invested by funds: $29.5M → $44.6M (+$15.1M)

10.52% more ownership

Funds ownership: 29.74% → 40.26% (+11%)

9% more funds holding

Funds holding: 44 → 48 (+4)

85% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 20

Holders
48
Holders Change
+4
Holders Change %
+9.09%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
3
Reduced
20
Closed
4
Calls
$258K
Puts
$73K
Net Calls
+$185K
Net Calls Change
-$93K

Top Buyers

Rank Fund Capital Flow
1
DC
Davenport & Co
Virginia
+$18.4M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$675K
3
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$574K
4
Citadel Advisors
Citadel Advisors
Florida
+$520K
5
IAIM
International Assets Investment Management
Florida
+$163K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$2.6M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$960K
3
TRCT
Tower Research Capital (TRC)
New York
-$676K
4
FTUS
Flow Traders U.S.
New York
-$268K
5
Morgan Stanley
Morgan Stanley
New York
-$261K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
26
IFP Advisors
Florida
$171K -$22.2K -739 -14%
Osaic Holdings
27
Osaic Holdings
Arizona
$111K -$56.3K -1,872 -34%
William Blair & Company
28
William Blair & Company
Illinois
$102K – – –
AWM
29
AllSquare Wealth Management
New York
$96K – – –
Carson Wealth (CWM LLC)
30
Carson Wealth (CWM LLC)
Nebraska
$55K +$54.2K +1,800 New
BAM
31
Belpointe Asset Management
Nevada
$51.1K +$50.6K +1,681 New
US Bancorp
32
US Bancorp
Minnesota
$30.4K – – –
CT
33
Cambridge Trust
Massachusetts
$17K – – –
HWM
34
HighMark Wealth Management
Minnesota
$16.7K – – –
NA
35
NewEdge Advisors
Louisiana
$12.2K +$12K +400 New
CG
36
Cutler Group
California
$11K -$602 -20 -5%
First Manhattan
37
First Manhattan
New York
$9.11K – – –
S
38
SignatureFD
Georgia
$6.08K – – –
KIA
39
Kraematon Investment Advisors
Massachusetts
$5.17K +$5.12K +170 New
ADL
40
Asset Dedication LLC
California
$5K – – –
ASN
41
Advisory Services Network
Georgia
$4.56K +$4.51K +150 New
VNA
42
Valley National Advisers
Pennsylvania
$4K – – –
FFA
43
Farther Finance Advisors
California
$3.89K +$3.85K +128 New
TRCT
44
Tower Research Capital (TRC)
New York
$3K -$676K -22,456 -100%
FCB
45
First Command Bank
Texas
$3K – – –
FCFS
46
First Command Financial Services
Texas
$3K – – –
Rockefeller Capital Management
47
Rockefeller Capital Management
New York
$1K – – –
AFG
48
Albion Financial Group
Utah
$365 – – –
FTUS
49
Flow Traders U.S.
New York
– -$268K -8,894 Closed
CFD
50
Creative Financial Designs
Indiana
– -$15K -500 Closed
1
2
3

SBIO Hedge Fund Activity: Q4 2022 in Review

48 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2022, worth a combined $44.6M — up 51% from $29.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new SBIO positions and 4 closed out — a net gain of 5 holders — while 3 added to existing stakes and 20 trimmed.

The largest buyer was Davenport & Co, opening a new position worth an estimated $18.4M. The largest seller was UBS Group, cutting an estimated $2.6M.

  • 48 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2022, up from 44 in Q3 2022.
  • Funds reported $44.6M of ALPS Medical Breakthroughs ETF stock for Q4 2022, up 51% quarter-over-quarter.
  • 9 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2022 and 4 closed out, a net change of +5 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2022 was Davenport & Co, an estimated $18.4M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2022 was UBS Group, an estimated $2.6M sold.

Based on aggregated 13F filings for Q4 2022.